News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Sandoz announces partnership agreement with Samsung Bioepis on up to five biosimilars, further expanding its leading pipeline to up to 32 assets
Sandoz partners with Samsung Bioepis on up to five biosimilars, expanding its pipeline to 32 assets. The agreement aims to broaden patient access to high-quality medicines worldwide -